enGenome
PrivateLast Round
Accelerator
Oct 14, 2021
Total Funding Raised
$4.29M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
enGenome operates in Healthcare & Life Sciences and is based in Pavia. Its latest recorded funding round was an Accelerator round in October 2021.
enGenome is a bioinformatics company that provides an AI-powered software platform for genomic data analysis and interpretation to support the diagnosis of genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Precision Medicine, Biotechnology, Healthcare Analytics, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
enGenome Comparables
Compare enGenome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Limbus Medical Technologies | 88% | |
| Saphetor | 88% | |
| GenomeUp | 86% |
For institutional investors. Book with your work email.
enGenome Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
enGenome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 75% MoM.
- Dec 9, 2025
Monthly visitors increased 64% MoM, reaching 5.8K.
For institutional investors. Book with your work email.
enGenome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about enGenome's valuation, stock price, and market status.
Is enGenome a public or private company?
enGenome is a private company.
What is the current stock price of enGenome?
enGenome is a private company, so its shares have no public market price. Caplight tracks enGenome's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is enGenome worth (valuation)?
Valuation information for enGenome is not publicly available.
Can I buy enGenome stock?
enGenome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was enGenome's last funding round?
enGenome's most recent funding round was Accelerator on October 14, 2021.
Who are the main investors in enGenome?
Key investors in enGenome include European Innovation Council Fund.
Will enGenome IPO soon?
No public IPO plans have been announced for enGenome.
How can I track enGenome secondary market activity?
Caplight tracks bids, offers, and trades in enGenome's shares on secondary markets.